Skip to main content

Zevra Therapeutics, Inc 10-Q for FY2023 Q1

Zevra Therapeutics, Inc. (ZVRA)

10-Q 2023-05-15 For: 2023-03-31
View Original
Added on April 10, 2026

About this 10-Q

Zevra Therapeutics, Inc filed this 10-Q on May 15, 2023, covering the quarter ended March 31, 2023 (FY2023 Q1).

Headline figures

Quarter ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$2.88M
down 27.4% from $3.97M a year earlier
Net loss
$11.77M
compared with a net loss of $1.86M a year earlier